🇺🇸 FDA
Patent

US 10982221

Plant-derived antibodies and derivatives that reduce risk of antibody-dependent enhancement (ADE) of infection

granted A61KA61K2039/505

Quick answer

US patent 10982221 (Plant-derived antibodies and derivatives that reduce risk of antibody-dependent enhancement (ADE) of infection) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505